UPDATE: Reyes denies diagnosis on thyroid

0 Comments

jose reyes headshot mets.jpgUpdate: Here’s a quote from the translated version, available on ESPN.com:

“The specialists who took care of me in New York have told me that I’m
fine and that there’s nothing wrong with my thyroid. The test [taken to
follow one conducted during his physical] showed that I’m fine. We just
have to wait for the results of the additional test. The [doctors] found
inflammation in my throat and no medicine to treat the thyroid or any
other condition has been prescribed.

We await some clarification from the team on Wednesday.

10:40 pm: Interesting. According to Enrique Rojas of ESPN Deportes, Jose Reyes denied reports about his thyroid, stating that he only had inflammation in his throat and did not need drugs for a thyroid condition. Reyes said that he was only told to avoid seafood because of its iodine content and be checked out every three weeks.

Of course, there is a relationship between iodine and the thyroid gland, so perhaps there’s some semantics at play here — or my Google translator is completely wrong. Reyes acknowledged that he is still awaiting results of a second test, so a full course of action hasn’t been determined yet.

7:00 pm: According to Adam Rubin of the New York Daily News, Jose Reyes has been diagnosed with an overactive thyroid. The club would reveal little else this evening, other than to say Reyes will remain in New York for additional tests to determine treatment. Results of the tests are not expected before Thursday.

A well-deserved dark cloud follows nearly every medical situation surrounding the Mets at this point, but this particular thyroid condition is not considered serious and is fully-treatable with medication. There’s no word on when Reyes will be able to resume baseball activities, but this figures to be only a minor setback.
 

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.